Harm Reduction Therapeutics, Inc.

First Shipment of RiVive(TM) Brings Life-saving Over-The-Counter Naloxone Nasal Spray One Step Closer to Those Who Need It Most
RiVive™ is now available - Remedy Alliance has begun distributing RiVive to community harm reduction groups working to save lives that would otherwise be lost to opioid overdoseNonprofit Harm Reduction Therapeutics will begin fulfilling orders for RiVive more broadly in early 2024, making it available across the US for free of charge or at a low breakeven cost Harm Reduction Therapeutics is seeking additional funding partners who can save lives by helping to increase the manufacturing of RiVive, further lower...
2023-12-18 9:00 AM EST
FDA Approval of RiVive(TM) Is a Critical Milestone in Making Emergency Treatment of Opioid Overdose More Widely Available
RiVive™, a naloxone nasal spray that is easy to use, will be available over-the-counter Unlike other opioid overdose products, Harm Reduction Therapeutics will make RiVive™, which can save lives, available for free or at low breakeven costPittsburgh, Pennsylvania--(Newsfile Corp. - July 28, 2023) - Harm Reduction Therapeutics (HRT), Inc., a nonprofit pharmaceutical company, announced today that FDA has approved OTC RiVive™ (naloxone HCl nasal spray 3 mg) for the emergency treatment of opioid overdose. This critical milestone will help prevent...
2023-07-28 1:45 PM EDT